Skip to main content

Announcements & Media Coverage


“Data from consumer product trials now available through Yale YODA Project” (Yale News, February 1, 2017)

In January 2017, the YODA Project submitted comments on the PCORI Data Access and Data Sharing Draft Policy.

In January 2017, the YODA Project submitted comments on the NIH Request for Information on Strategies for NIH Data Management, Sharing, and Citation.

“The push for more clinical research data sharing is paying off” (Yale News, August 3, 2016)

“Transparency in research: SI-BONE to make clinical trial data accessible via Yale YODA Project” (Yale News, May 12, 2016)

In April 2016, the YODA Project submitted comments on the International Committee of Medical Journal Editors’ Proposal for Sharing Clinical Trial Data.

In November 2015, the YODA Project submitted comments on the proposed Policy and Implementation Plan for Public Access to Scientific Publications and Digital Data from Research Funded by the Department of Veterans Affairs.

In March 2015, the YODA Project submitted comments in response to the NIH Request for Public Comments on the Draft NIH Policy on Dissemination of NIH-Funded Clinical Trial Information.

In March 2015, the YODA Project submitted comments in response to the Publication of Notice of Proposed Rulemaking for Clinical Trials Registration and Results Submission under FDAAA.

“Against the odds, Yale improves access to data” (Yale Daily News, January 28, 2015)

“Yale YODA Project announces first availability of medical device trial data” (Yale News, January 14, 2015)

“Yale program now processing requests for Johnson & Johnson pharmaceutical clinical trial data” (Yale News, October 20, 2014)

Video: “Whose data is it, anyway?” (YaleMedicine, March 13, 2014)

“Yale program’s agreement with Johnson & Johnson allows broad access to clinical trial data” (Yale News, January 30, 2014)

“Safety Review of Bone Growth Product Ushers in New Era of Data Sharing” (Yale News, June 17, 2013)

“Yale Selects Two Research Centers to Review Safety of Bone Growth Product” (Yale News, December 5, 2011)

Media Coverage

“Data Sharing in Action: When Drug Companies Open Their Trial Vaults” (The Scientist, December 3, 2018)

James J. Unlock the Power of Data. (Pharma Tech Outlook - CXO Insights, May 2017)

Johnson & Johnson Invests More Data In YODA Project” (Clinical Informatics News, March 15, 2017)

Wallach JD, Ross JS, Krumholz HM. Advancing meta-research through data sharing and transparency. (BioMed Central Blog Network, February 15, 2017)

“Opening up clinical data on new medicines” (European Medicines Agency, October 20, 2016)

Dr. Harlan Krumholz on the movement toward broader, responsible, productive sharing of data from clinical trials” (NEJM, August 3, 2016)

Johnson & Johnson Announces Open Translational Science Project in Schizophrenia” (OPTICS, June 9, 2015)

“WHO Joins the Push for Greater Disclosure of Clinical Trial Data” (Wall Street Journal, April 15, 2015)

J&J Opens Up Data From Medical Device Clinical Trials” (Medical Device and Diagnostic Industry, January 20, 2015)

“Data Sharing Takes Two Steps Forward” (Genetic Engineering and Biotechnology News, January 15, 2015)

“Drug researchers hide thousands of negative studies. A new campaign is trying to change that.” (Vox, January 14, 2015)

“Institute of Medicine Urges Broader Sharing of Clinical Trial Data” (Wall Street Journal, January 14, 2015)

“Buried Clinical Trial Data: The Dam Is About To Burst” (Forbes, January 14, 2015)

“J&J becomes first devicemaker to broadly share trial data” (Modern Healthcare, January 14, 2015)

“Johnson & Johnson to Make Clinical Data Available to Outside Researchers” (New York Times, January 14, 2015)

“Why It’s About to Get A Lot Harder to Hide the Results of Medical Studies” (Vox, December 8, 2014)

“How Sharing Your Health Data Could Change Medical Research” (Time, December 5, 2014)

“What Happens When Results Data From Clinical Trials Goes Missing” - subscription required (Wall Street Journal, December 4, 2014)

“Patients’ and doctors’ campaign welcomes plans to tackle unjust and dangerous problem of hidden clinical trials” (AllTrials, November 20, 2014)

“NIH and FDA Toughen Rules for Reporting Clinical Trial Results” (Wall Street Journal, November 19, 2014)

“Secret Clinical Trial Data to Go Public” (Scientific American, June 1, 2014)

“Sharing the Wealth” (The Scientist, May 1, 2014)

“Prof. pushes for release of Vioxx documents” (The Brown Daily Herald, April 7, 2014)

“Straight Talk With…Harlan Krumholz” (Nature Medicine, March 4, 2014)

“J&J puts trial data in independent hands” (chemistryworld, February 4, 2014)

“Give the Data to the People” (New York Times, February 3, 2014)

“J&J to allow access to clinical research through Yale open-data project” (Modern Healthcare, January 30, 2014)

“Johnson & Johnson Announces Clinical Trial Data Sharing Agreement with Yale School of Medicine” (Johnson & Johnson, January 30, 2014)

“Johnson & Johnson Will Share Clinical Trial Data” (Forbes, January 30, 2014)

“In Stunning Win For Open Science, Johnson & Johnson Decides To Release Its Clinical Trial Data To Researchers” (Forbes, January 30, 2014)

“J&J chooses Yale to review requests for clinical drug data” (Reuters, January 30, 2014)

“J&J to Share Drug Research Data in Pact With Yale” - subscription required (Wall Street Journal, January 30, 2014)

“J&J Sets Drug Data Free in ‘YODA’ Collaboration With Yale” (Bloomberg, January 30, 2014)

“J&J’s Clinical Data Disclosure Strategy Focuses On Collaboration With Yale University Group” - subscription required (Informa, January 30, 2014)

“J&J Opens Data Vault to Yale, in ‘Unprecedented’ Transparency Move” (Xconomy, January 30, 2014)

“Medtronic’s Infuse No Better than Bone Graft with More Risk” (Bloomberg Businessweek, June 18, 2013)

“Long-awaited Yale Study Raises Questions about Integrity of Previous Studies of Medtronic’s Infuse” (Minneapolis Star Tribune, June 18, 2013)

“Outside Review of Clinical Data Find a Spinal Treatment’s Benefit Overstated” (New York Times, June 17, 2013)

“Studies Fail to Back Medtronic Drug Claims” (Wall Street Journal, June 17, 2013)

“Medtronic Bone Graft has Limited Benefit, May Cause Harm- Reviews” (Reuters, June 17, 2013)

“Data Reviews Question Use of rhBMP-2 in Spinal Fusion” (Medscape, June 17, 2013)

“Report Deals Another Blow to Synthetic Bone Growth Product” (Stanford Medicine, June 17, 2013)

“More Lessons from the BMP Trials Controversy” (The Daily Edition - AAOS Now, February 10, 2012)

“The Aftermath of the BMP-2 Crisis: Restoring Confidence in Spine Research and Spine Care” (The Back Letter, Vol. 26, No. 11, November 2011)

“Yale Doc Weighs In on Medtronic’s Infuse” (, November 14, 2011)

“Did Medtronic Sell an Unsafe Product?” (Minneapolis Star Tribune, November 14, 2011)

“Yale Docs Propose Model to Aid True, Evidence-based Medicine” (, October 13, 2011)

“Unprecedented Access” (BMJ Podcast, September 9, 2011)

“Medtronic Submits Full Data on Spinal Protein to Independent Scrutiny” (BMJ, August 30, 2011)

“Medtronic Hires Yale Experts for Spine Drug Review”  (Reuters, August 4, 2011)

“Medtronic Giving Yale Grant to Review Bone Growth Data” (New York Times, August 3, 2011)

“Medtronic Engages Yale University to Oversee Independent, Systematic Reviews of Recombinant Bone Morphogenic Protein-2: First of its Kind Post-Review Website to Provide Scientific Access to Full Clinical Data” (Business Wire, August 3, 2011)